Jahr Robert Charles bought OTLK
July 1, 2025 · Form 4 insider transaction
Jahr Robert Charles bought 800,000 shares of Outlook Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Acquired (buy-side)
Shares
800,000
Price
$0.00
Total value
N/A
InsiderJahr Robert Charles
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2025
Filing dateJuly 9, 2025
Shares owned after800,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date.